Paloma Partners’s Corvus Pharmaceuticals CRVS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-39,787	Closed	-$149K	–	1640
2019 Q2	$149K	Buy	+39,787	New	+$149K	﹤0.01%	1341
2019 Q1	–	Sell	-15,900	Closed	-$58K	–	1372
2018 Q4	$58K	Buy	+15,900	New	+$58K	﹤0.01%	916